MELA Sciences (NASDAQ:MELA)

CAPS Rating: 2 out of 5

A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.

Recs

0
Player Avatar contrarianjim (23.84) Submitted: 11/17/2010 4:34:14 PM : Outperform Start Price: $5.45 MELA Score: -60.82

Can you say FDA won't let this one get away

Featured Broker Partners


Advertisement